 not robust concerning intervals
for follow-up imaging, the committee was unanimous in
this recommendation, recognizing that follow-up DUS
carries little risk.
6. Imaging after CAS or CEA is indicated to monitor
contralateral disease progression in patients with contralateral stenosis â±–50%. In patients with multiple risk
factors for vascular disease, follow-up DUS may be
indicated with lesser degrees of stenosis. The likelihood
of disease progression is